Remove Health Care Reform Remove Medicare Remove Pharmaceutical Industry Related Topics
article thumbnail

US Rep. Gaetz’s Diagnosis of What’s Driving Insulin Costs Misses the Root Cause

Kaiser Health News

However, the pharmaceutical industry disagrees with this assessment. The House bill would cap the cost of insulin at $35 per month for individuals who have private insurance or for those on Medicare. However, the bill does nothing to help the uninsured who need insulin.